Advances in PD-1 and PD-L1 inhibitors targeted therapies for NSCLC: Mechanisms, Biomarkers, Combination Therapies
BIO Web Conf., 174 (2025) 02013
DOI: https://doi.org/10.1051/bioconf/202517402013
EDPS Account
